stella
beta
Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer — Stella
Recruiting
Back to Lung Cancer (NSCLC) trials
Trial locations
(4 sites)
China
Peking University Cancer Hospital & Institute, Beijing, Beijing Municipality
Peking University Third Hospital, Beijing, Beijing Municipality
Inner Mongolia Hospital of Peking University Cancer Hospital, Hohhot, Inner Mongolia
The Third Affliated Hospital of Kunming Medical University, Kunming, Yunnan
View full record on ClinicalTrials.gov